Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Illumina, Inc. (ILMN) – Illumina, Inc. Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Illumina (ILMN) is trading at $122.26, down 4.48% on the day, with a technical picture showing a bearish signal near key support at $121. The company has demonstrated strong recent earnings beats, with profitability metrics like a 19.57% net income margin for 2025 indicating a significant turnaround from prior losses. Positive business momentum is supported by strategic collaborations, such as the expanded partnership with Labcorp announced on March 18, 2026, to advance precision oncology testing.
The outlook is mixed: a bullish analyst consensus price target of $153.00 suggests ~25% upside, but the stock faces risks from its high debt-to-asset ratio and recent institutional selling. The key catalyst is the upcoming Q1 2026 earnings report on April 30, 2026, which will test the sustainability of the company's profit recovery.
Read full analysis

Key Stats

  • Market Cap
    $18.91B
  • Sector
    Health
  • 3M Drawdown
    -25.66%
  • Enterprise Value
    $19.83B
  • Dividend Yield
    -
  • Trading Activity
    0% Buy | 100% Sell
  • Typical Hold Time
    85 days
$121.1
52W Low: $71.16
17 Apr 2025
52W High: $153.95
22 Jan 2026

Illumina, Inc. (ILMN) is currently valued at a market capitalization of $18.91B, with an enterprise value of $19.83B. Over the past 52 weeks, Illumina, Inc. has traded between a low of $71.16 and a high of $153.95, highlighting its annual price range. Over the past three months, Illumina, Inc. has recorded a drawdown of -25.66%, reflecting recent price volatility. Illumina, Inc. offers a dividend yield of -. On average, investors hold Illumina, Inc. for approximately 85 days, indicating typical investor behavior on the platform.

About Illumina, Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.


Technical Indicators
|
|
|
Overall Summary
Bearish (14)Neutral (2)Bullish (11)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $18.91B
  • Sector
    Health
  • 3M Drawdown
    -25.66%
  • Enterprise Value
    $19.83B
  • Dividend Yield
    -
  • Trading Activity
    0% Buy | 100% Sell
  • Typical Hold Time
    85 days
$121.1
52W Low: $71.16
17 Apr 2025
52W High: $153.95
22 Jan 2026

Illumina, Inc. (ILMN) is currently valued at a market capitalization of $18.91B, with an enterprise value of $19.83B. Over the past 52 weeks, Illumina, Inc. has traded between a low of $71.16 and a high of $153.95, highlighting its annual price range. Over the past three months, Illumina, Inc. has recorded a drawdown of -25.66%, reflecting recent price volatility. Illumina, Inc. offers a dividend yield of -. On average, investors hold Illumina, Inc. for approximately 85 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!